The plan sets targets at two horizons. By 2027 the province intends to complete development and medical device registration for three invasive and five non-invasive BCI products, carry out its first invasive BCI operation, and serve more than 50,000 patients a year through open medical scenarios. By 2030 it aims to cultivate 10 chain-leading companies, 100 specialised SMEs and 200 innovative smaller firms, to perform 3,000 invasive BCI procedures a year, to serve more than 100,000 patients a year with neurodegenerative disease, psychiatric conditions and drug or digital addiction, and to record more than 20,000 rehabilitation device sessions a year.
For delivery the plan adopts a two-way open competition mechanism in which companies post technical needs and research teams post results seeking markets, and it advances invasive and non-invasive routes in parallel. Geographically, it directs Chengdu, Mianyang, Deyang and Nanchong to attract chain-leading, backbone, supporting and service firms, and backs Chengdu in establishing a manufacturing innovation centre for the sector. Issued by the provincial industry regulator with seven co-signatories, it is Sichuan’s first dedicated provincial document in this field.